Ron Wyden

I am all-in for Senator Cardin's program.

Deamonte Driver was a 12-year-old who lived in Prince George's County, MD, about 7 miles from here.

Senator Stabenow has been one of the great leaders on health care in the U.S. Senate.

Disparities in our health-care system are well documented, and the impact they have in regard to vulnerable communities.

This is more reason for the Congress and this Committee to step in and do this job and do it in a bipartisan way.

There are clearly too many jobs in the Federal government that require a security clearance.

Senator Moynihan always stood for the proposition that a big part of the job in intelligence is striking the balance between transparency and protecting sources and methods.

One of the reasons is that there are too many secrets of matters that do not need to be secret.

I think your answer is spot-on, and I would be interested in any information you have or could supply.

I am all-in for Senator Cardin's program.

I think we can do this. I think we can do it in a fiscally responsible way.

Senator Cardin has been after these issues for years and years, before they became popular.

Senator Stabenow has been one of the great leaders on health care in the U.S. Senate.

Disparities in our health-care system are well documented, and the impact they have in regard to vulnerable communities.

Deamonte Driver was a 12-year-old who lived in Prince George's County, MD, about 7 miles from here.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.

In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

The consequences of this out-of-whack market are felt by taxpayers and American families every time they pick up a prescription at the pharmacy counter.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?

I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.

NACDS applauds Chairman Wyden and Ranking Member Crapo for keeping this issue top of mind on a bipartisan basis.